IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 142 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,504,790 | -7.3% | 121,452 | -22.5% | 0.19% | -31.5% |
Q3 2022 | $1,623,000 | +28.8% | 156,626 | +43.4% | 0.28% | -9.1% |
Q2 2022 | $1,260,000 | -8.3% | 109,240 | 0.0% | 0.31% | +10.0% |
Q1 2022 | $1,374,000 | -46.1% | 109,240 | -50.0% | 0.28% | +6.9% |
Q4 2021 | $2,548,000 | +78.6% | 218,480 | +100.0% | 0.26% | -16.1% |
Q3 2021 | $1,427,000 | +54.8% | 109,240 | +52.5% | 0.31% | +87.3% |
Q2 2021 | $922,000 | +15.4% | 71,615 | +0.2% | 0.17% | +13.7% |
Q1 2021 | $799,000 | -1.8% | 71,494 | 0.0% | 0.15% | -16.1% |
Q4 2020 | $814,000 | +66.5% | 71,494 | +31.5% | 0.17% | +34.9% |
Q3 2020 | $489,000 | -12.8% | 54,350 | 0.0% | 0.13% | -9.2% |
Q2 2020 | $561,000 | +2.4% | 54,350 | 0.0% | 0.14% | -15.5% |
Q1 2020 | $548,000 | -6.0% | 54,350 | +24.0% | 0.17% | +54.1% |
Q4 2019 | $583,000 | -52.9% | 43,816 | -43.4% | 0.11% | -53.8% |
Q1 2015 | $1,238,000 | – | 77,359 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |